Notes in Ependymoma

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	Craniospinal RT
Published	02/18/2024	CNS \| Ependymoma \| 1.1 \| Definition
Published	02/18/2024	CNS \| Ependymoma \| 1.2 \| Epidemiology
Published	02/18/2024	CNS \| Ependymoma \| 1.3 \| Risk factors
Published	02/18/2024	CNS \| Ependymoma \| 1.4 \| Classification
Published	02/18/2024	CNS \| Ependymoma \| 1.5 \| Macroscopic and microscopic appearance
Published	02/18/2024	CNS \| Ependymoma \| 1.6 \| Biologic behaviour
Published	02/18/2024	CNS \| Ependymoma \| 1.7 \| Clinical presentation
Published	02/18/2024	CNS \| Ependymoma \| 1.8 \| Imaging appearance
Published	02/18/2024	CNS \| Ependymoma \| 1.9 \| Prognostic factors
Published	02/18/2024	CNS \| Ependymoma \| 2 \| Workup
Published	02/18/2024	CNS \| Ependymoma \| 3.2.1 \| Managment \| Intracranial tumours \| Surgery
Published	02/18/2024	CNS \| Ependymoma \| 3.2.2 \| Intracranial \| Adjuvant radiotherapy
Published	02/18/2024	CNS \| Ependymoma \| 3.3.1 \| Spinal cord \| Surgery
Published	02/18/2024	CNS \| Ependymoma \| 3.3.2 \| Spinal cord \| Adjuvant radiotherapy
Published	02/18/2024	CNS \| Ependymoma \| 3.4 \| Chemotherapy
Published	02/18/2024	CNS \| Ependymoma \| 3.5 \| Myxopapillary ependymoma
Published	02/18/2024	CNS \| Ependymoma \| 4 \| Follow up
Published	02/18/2024	CNS \| Ependymoma \| 5 \| Recurrence
Published	02/18/2024	CNS \| Ependymoma \| 6 \| Outcomes
Published	02/18/2024	CNS \| Ependymoma \| 7 \| RT technique
Published	02/18/2024	CNS \| Ependymoma \| 8 \| COG annual follow up guideline
Published	02/18/2024	CNS \| Ependymoma \| 3.1 \| Management overview
Status	Last Update	Fields